11.07.2015 Views

FINAL PROGRAM - American Society of Gene & Cell Therapy

FINAL PROGRAM - American Society of Gene & Cell Therapy

FINAL PROGRAM - American Society of Gene & Cell Therapy

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

13 th AnnUAL MEETing | Washington, DC USA May 19-22, 2010115Abstract DirectoryFriday, May 21, 2010Poster Session II— continued6:30 PM - 8:30 PMRoom: Exhibit Hall C & B-SouthMusculo-skeletal <strong>Gene</strong> & <strong>Cell</strong> <strong>Therapy</strong> II467Detailed Physical Mapping <strong>of</strong> Deletion Breakpoints in the GSHP DogModel for DMDAlock Malik, Acong Xu, Jesse Chen, Andrew Mead, Martin Childers, Janet Bogan, ScottSchatzberg, Joe Kornegay, Hansell Stedman.468Lentiviral Vector Mediated Delivery <strong>of</strong> Full-Length Dystrophin for<strong>Gene</strong> <strong>Therapy</strong> <strong>of</strong> Muscular DystrophyEn Kimura, Katsuhisa Uchio, Tomohiro Suga, tatsuya Koide, Yuji Uchida, Yasushi Maeda,Satoshi Yamoshita, Jeffrey S. Chamberlain, Makoto Uchino.Cancer – Immunotherapy II469Elimination <strong>of</strong> Cancer Stem <strong>Cell</strong>s with <strong>Gene</strong>tically Engineered T <strong>Cell</strong>sExpressing a Stage Specific Embryonic Antigen-1 (SSEA1) ChimericAntigen ReceptorAntonina V. Kurtova, Juan Vera, An Lu, Adham Bear, Aaron E. Foster.470Targeting Cancer Stem <strong>Cell</strong>s in OsteosarcomaAlexia Ghazi, Nino Rainusso, Vita Salsman, Helen Heslop, Steven Gottschalk, NabilAhmed.471CMV-Specific HER2-Redirected T <strong>Cell</strong>s for the AdoptiveImmunotherapy <strong>of</strong> GlioblastomaAlexia Ghazi, Vita Salsman, Yvonne Kew, Donald Shaffer, Suzanne Powell, RobertGrossman, Michael Scheurer, Ann Leen, Catherine Bollard, Helen Heslop, StephenGottschalk, Nabil Ahmed.472Combining mTor Inhibitors with Rapamycin-Resistant T <strong>Cell</strong>s: A Two-Pronged Approach to Tumor EliminationLeslie E. Huye, Barbara Savoldo, Gianpietro Dotti, Matthew H. Wilson, Cliona M. Rooney.473Evaluating the Combination <strong>of</strong> 5’Azacytidine and MAGE-A4-SpecificT <strong>Cell</strong> <strong>Therapy</strong> as a Potential Immunotherapeutic Strategy forRefractory Hodgkin’s LymphomaConrad R. Cruz, Ulrike Gerdemann, Jessica A. Shafer, Ann M. Leen, Tamara Tripic, TerzahM. Horton, Anas Younes, Cliona M. Rooney, Helen E. Heslop, Catherine M. Bollard.474The iCD40.MyD88 Dendritic <strong>Cell</strong> (DC) <strong>Gene</strong> Switch Leads to PotentAnti-Tumor <strong>Therapy</strong>Natalia Lapteva, Priyadharshini Narayanan, Mamatha Seethammagari, Kevin M. Slawin,David M. Spencer.475Emozolomide Inhibits the Migration <strong>of</strong> Immune <strong>Cell</strong>s into the BrainTumor Microenvironment and Their Systemic Expansion, but Exertsa Synergistic Anti-Tumor Effect When Combined with CombinedConditional Cytotoxic/Immune-<strong>Gene</strong> <strong>Therapy</strong>Maria G. Castro, Marianela Candolfi, Kader Yagiz, Kurt M. Kroeger, David Foulad,Garbielle Ahlzadeh, Matthew Tesarfreund, Pedro R. Lowenstein.476TCR Engineered and In Vitro Expanded T Lymphocytes Recapitulatethe Properties <strong>of</strong> Central Memory T <strong>Cell</strong>sShicheng Yang, Zhili Zheng, Ling Zhang, Steven A. Rosenberg, Richard A. Morgan.477Phase I Safety and Immunogenicity <strong>of</strong> HPV 16 and 18 DNA VaccinesDelivered Via ElectroporationJian Yan, Panyupa Pankhong, Xuefei Shen, Mary Giffear, Jessica Lee, Drea Harris,Deanna Diaz, Amir Khan, Mark Bagarazzi, Jean Boyer, David B. Weiner, Niranjan Y.Sardesai.478Improving Adoptive T <strong>Cell</strong> <strong>Therapy</strong> by Transduction <strong>of</strong> TIL with aVector That Mediates the Inducible Expression <strong>of</strong> IL-12 in the TumorMicroenvironmentLing Zhang, Sid P. Kerkard, Shicheng Yang, Zhili Zheng, Zhiya Yu, Nichaolas P. Restifo,Steven A. Rosenberg, Richard A. Morgan.479Robust and Sustained Ex Vivo Expansion <strong>of</strong> NK <strong>Cell</strong>s with ArtificialAPCs Bearing Membrane-Bound IL-21 Is Associated with a DistinctPhenotype and Transcriptional Pr<strong>of</strong>ileCecele J. Denman, Vladimir Senyukov, Lisa M. Kopp, Maria Lima de Silva, Harjeet Singh,Lenka Hurton, Simon Olivares, Sourindra Maiti, Mary H. Huls, Richard E. Champlin,Laurence J. N. Cooper, Dean A. Lee.480STAT3-Inactivated Dendritic <strong>Cell</strong> Vaccination Could Induce StrongerAnti-Tumor Immune ResponsesHidetoshi Sumimoto, Tomoko Iwata-Kajihara, Hiroyuki Mizuguchi, Kiyoshi Takeda,Yutaka Kawakami.481Combination <strong>Therapy</strong> for Melanoma Using Virotherapy and AlternateTLR Stimulating AgonistsRosa Diaz, Marta Compte-Grau, Elizabeth Ilett, Phonphimon Wongthida, Feorillo Galivo,Timothy Kottke, Jill Thompson, Alan Melcher, Richard Vile.482Bid Is a Key Factor for Eliciting the Antiproliferative Activity <strong>of</strong> IFN-aMediated by TRAILTakaya Tsuno, Josef Mejido, Tongmao Zhao, Terry Phillips, Kathryn Zoon.483Oral Adeno-Associated Virus-neu (AAV-neu) Immunotherapy Inhibitsthe Growth <strong>of</strong> neu+ Murine Breast CancerJason C. Steel, Giovanni Di Pasquale, Charmaine A. Ramlogan, Caroline Morris, John A.Chiorini, John C. Morris.Friday, May 21 st

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!